Life Sciences Commons^™

Internal Disinhibition Predicts Weight Regain Following Weight Loss And Weight Loss Maintenance, Heather M. Niemeier, Suzanne Phelan, Joseph L. Fava, Rena R. Wing

Kinesiology and Public Health

Objective: The disinhibition scale of the Eating Inventory predicts weight loss outcome; however, it may include multiple factors. The purpose of this study was to examine the factor structure of the disinhibition scale and determine how its factors independently relate to long-term weight loss outcomes.
Research Methods and Procedures: Exploratory factor analysis of the disinhibition scale was conducted on 286 participants in a behavioral weight loss trial (TRIM), and confirmatory factor analysis was conducted on 3345 members of the National Weight Control Registry (NWCR), a registry of successful weight loss maintainers. Multivariate regressions were used to examine the relationships between …

Three-Year Weight Change In Successful Weight Losers Who Lost Weight On A Low-Carbohydrate Diet, Suzanne Phelan, Holly Wyatt, Shirine Nassery, Julia Dibello, Joseph L. Fava, James O. Hill, Rena R. Wing

Kinesiology and Public Health

Objective: The purpose of this study was to evaluate long-term weight loss and eating and exercise behaviors of successful weight losers who lost weight using a low-carbohydrate diet.
Research Methods and Procedures: This study examined 3-year changes in weight, diet, and physical activity in 891 subjects (96 low-carbohydrate dieters and 795 others) who enrolled in the National Weight Control Registry between 1998 and 2001 and reported ≥ 30-lb weight loss and ≥ 1 year weight loss maintenance.
Results: Only 10.8% of participants reported losing weight after a low-carbohydrate diet. At entry into the study, low-carbohydrate diet users reported consuming more …

Impact Of Weight Loss On The Metabolic Syndrome, Suzanne Phelan, T. A. Wadden, R. I. Berkowitz, D. B. Sarwer, L. G. Womble, R. K. Cato, R. Rothman

Kinesiology and Public Health

Objective:
To evaluate the effects of weight loss on the risk of having metabolic syndrome after 1 year of treatment with lifestyle modification alone, pharmacotherapy alone (sibutramine) or the combination of the two.

Design:
Randomized, controlled, 1-year clinical trial.

Patients:
One hundred and eighty women and 44 men, 18–65 years of age, with a body mass index of 30–45 kg/m2, free of uncontrolled hypertension or type 1 or 2 diabetes.

Intervention:
Fifteen milligrams of sibutramine per day alone, lifestyle modification counseling alone, sibutramine plus lifestyle modification counseling or sibutramine plus brief lifestyle modification counseling.

Measurements:
The metabolic syndrome, as defined …